In today’s dish, a SPAC is set to take a Canadian late-stage biopharmaceutical company public. Also, shares in an EV charging company fall after it announces plans to r…
© 2024 Bill SPACman 📈
Substack is the home for great culture
In today’s dish, a SPAC is set to take a Canadian late-stage biopharmaceutical company public. Also, shares in an EV charging company fall after it announces plans to r…